Western blot analysis showed that 1 markedly reduced the levels of procaspases-3, 8, and 9, while being increased the levels of cleaved caspases-3, 8, and 9. In addition, compound 1 increased significantly Bax/Bcl-2 ratio. These results suggested that 1 induced apoptotic cell death in HL-60 via both mitochondrial and death receptor-mediated pathways. Therefore, compound 1 may be promising lead compound for developing an effective drug for treatment of leukemia. Flow cytometric analysis suggested that the cytotoxicity of 1 against AZ521 is due to inducing apoptosis as well as necrosis with the latter predominated.
Plants of the Meliaceae family have been well documented for the ability to metabolize structurally diverse and biologically significant limonoids and triterpenoids.
1) Melia azedarach L. (Meliaceae) is indigenous to Japan, Taiwan, China, and Southeast Asia. Its bark and fruit, which are known as "Kurenpi" and "Kurenshi," respectively, in Japan, have been used for vermicide, anodyne, and skin disease.
2,3) Many constituents including limonoids, triterpenoids, and steroids have been isolated from various parts of M. azedarach. [4] [5] [6] [7] [8] Several of the limonoids isolated from M. azedarach have been reported to possess cytotoxic, 9) antifeeding, 10) and insecticidal activities. 11) In the course of a search for potential bioactive compounds from Meliaceae plants, we have undertaken a detailed investigation on the limonoid constituents of Azadirachta indica (néem) seed extracts and have shown that some limonoids exhibit potent inhibitory activities against melanogenesis in B16 melanoma cells, against 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mice, and against TPA-induced Epstein-Barr virus early antigen (EBV-EA) activation, 12, 13) as well as cytotoxic and apoptosisinducing activities. 14) In a continuing study on the limonoid constituents of Meliaceae plants, we have investigated the fruit extract of M. azedarach, and have isolated a trichilintype limonoid, 12-O-acetylazedarachin B (1), which exhibited about 100-times higher cytotoxic activities against leukemia (HL-60) and stomach (AZ521) cancer cell lines than those of a positive control, cisplatin. Therefore, it might be useful for the development of an effective cancer drug to reveal the underlying mechanism of cytotoxic action by 1. In this paper, we report the isolation and identification of 1, the induction of apoptosis in HL-60 and AZ521 cells by 1, and the mechanisms of the apoptotic cell death.
MATERIALS ANd METHOdS
General NMR spectra were recorded with a JEOL ECX-400 ( Cell Cultures Cell lines HL-60 (leukemia), AZ521 (stomach), A549 (lung), and SK-BR-3 (breast) were obtained from Riken Cell Bank (Tsukuba, Ibaraki, Japan). Two cell lines, HL-60 and SK-BR-3, were grown in RPMI 1640 medium, while A549 and AZ521 cell lines were grown in dMEM and in 90% dMEM+ 10% MEM+ 0.1 mm NEAA, respectively. The medium was supplemented with 10% FBS and antibiotics. Cells were incubated at 37°C in a 5% CO 2 humidified incubator.
Isolation Procedure The air-dried fruits of M. azedarach (19.7 kg) were pulverized and extracted with n-hexane (2 L×3, 2 h each) under reflux, which gave an n-hexane extract (695 g). The defatted residue was, then, extracted with methanol (MeOH) (2 L×3, 3 d each) at room temperature to give MeOH extract (1036 g). The MeOH extract was suspended in water and partitioned with EtOAc to afford EtOAc (103 g) and H 2 O fractions. A portion of EtOAc fraction (91 g) was subjected to chromatography on a SiO 2 column (800 g).
Step gradient elution was conducted with n-hexane-EtOAc (1 : 0→ 0 : 1) to give 11 fractions: A-K, listed in increasing order of polarity. Fraction H (3.81 g), eluted with n-hexane-EtOAc (2 : 3), was subjected to further chromatography on silica gel [100 g; eluent: n-hexane-EtOAc (4 : 1→ 0 : 1)] to afford 11 fractions, H1-H11. Preparative HPLC of fraction H8 (292 mg), eluted with nhexane-EtOAc (11 : 9), gave compound 1 (4.2 mg, t R 24.0 min).
Cytotoxicity Assay Cytotoxicity assay was performed according to the method previously reported 15, 16) with HL-60, AZ521, A549, and SK-BR-3 cell lines (each 3×10 3 
cells in 100 µL).
Annexin V-Propidium Iodide (PI) Double Staining Annexin V-propidium iodide (PI) double staining was performed according to the method previously reported 15, 16) with HL-60 (10 5 cells in 5000 µL) and AZ521 (10 5 cells in 5000 µL). Cell Cycle Analysis Cell cycle analysis was performed according to the method previously reported 16) with HL-60 (10 5 cells in 5000 µL). Western Blot Analysis Western blot analysis was performed according to the previous method 15, 16) with HL-60 cells (1×10 5 cells in 5000 µL).
RESULTS AND DISCUSSION
12-O-Acetylazedarachin B (1) (Fig. 1) was isolated from the MeOH extract of defatted Melia azedarach fruit by silica gel column chromatography and RP preparative HPLC. Identification of 1 was performed by 17) The cytotoxic activity of compound 1 and two anticancer drugs, cisplatin and 5-fluorouracil (5-FU), were evaluated against four human cancer cell lines, HL-60 (leukemia), AZ521 (stomach), A549 (lung), and SK-BR-3 (breast), by means of a MTT assay, and the results are summarized in Table 1 . Compound 1 exhibited superior cytotoxic activity to positive controls against three cell lines, HL-60, AZ521, and A549. In particular, the cytotoxicities of compound 1 against HL-60 (IC 50 0.016 µm) and AZ521 (IC 50 0.035 µm) cells were about 100-times higher than those of cisplatin [IC 50 4.2 µm (HL-60) and 9.5 µm (AZ521)]. Compound 1, however, did not show cytotoxicity against SK-BR-3 cells. The potent cytotoxicity of 1 against HL-60 and AZ521, and non-activity against SK-BR-3 might be due to the presence of a cell-specific receptor that differentiates one tumor-type from another.
18) It is suggested that the target receptor of compound 1 does not exist in A549 and SK-BR-3 cells, or, if it existed, the receptor activated the anti-apoptotic signaling pathway. The cytotoxic and apoptosis inducing activities of compound 1 against HL-60 cells have been patented recently. 19) Melia azedarach have been known to contain various trichilin-type limonoids, and it was reported that trichilintype limonoids possessing one or two acetoxy groups in the structures exhibited strong cytotoxic activities against P388 mouse leukemia cells. 20, 21) Since compound 1 is a trichilintype limonoid with two acetoxy groups at C-3 and C-12 along with two hydroxy groups at C-1 and C-7, and showed potent cytotoxicities against HL-60 and AZ521 cells, this supports the previous finding on the structure-cytotoxicity relationships. 20, 21) In order to explore the nature of cytotoxicity of compound 1, this was subjected to annexin V-fluorescein isothiocyanate (FITC) and propidium iodide (PI) double staining for detection of early apoptotic cells, and 4′,6-diamidino-2-phenylindol (DAPI) staining for cell cycle analysis.
Compound 1 was evaluated for its apoptosis-inducing activity by flow cytometry of HL-60 cells stained with annexin V-FITC and PI. Exposure of the membrane phospholipid, phosphatidylserine, to the external cellular environment is one of the earliest markers of apoptotic cell death. 22) Annexin V is a calcium-dependent phospholipid binding protein with high affinity for phosphatidylserine expressed on the cell surface. PI does not enter a cell with intact cell-membrane and was used to differentiate between early apoptotic (annexin V-positive, PI-negative), late apoptotic (annexin V-, PI-double positive), or necrotic cell death (annexin V-negative, PI-positive). The ratio of early apoptotic cells (lower right) was increased after treatment with compound 1 (50 nm) in HL-60 for 24 h (from 0.5 to 9.4%) and 48 h (20.0%), and that of late apoptotic cells (upper right) was increased after 24 h (from 0.1 to 3.0%) and 48 h (21.3%) (Fig. 2A) . These results revealed that most of the cytotoxic activity of compound 1 against HL-60 cells is due to inducing apoptotic cell death.
Compound 1 was further evaluated for apoptosis-inducing activity against AZ521 cells by means of annexin V and PI double staining. The ratio of early apoptotic cells was increased, but only in a slight extent, after treatment with compound 1 (50 nm) for 24 h (from 2.6 to 3.1%) and for 48 h (7.6%), and that of late apoptotic cells was increased significantly for 48 h (from 5.2 to 58.0%) (Fig. 2B) . The ratio of necrotic cells (upper left) was, however, also increased after treatment with the compound for 48 h (from 3.7 to 18.9%). These results suggested that cytotoxicity of compound 1 against AZ521 cells is due to inducing apoptotic cell death as well as necrotic cell death with the latter predominated. The results are from one representative experiment among three runs, which showed similar patterns to one another.
Next, HL-60 cells were incubated with compound 1 (50 nm) for 24 and 48 h, and then the cells were analyzed in terms of cell cycle distribution by means of flow cytometry. The sub-G 1 peak, i.e., fragmented DNA, was quantified as the apoptosis index.
23) After treatment of 1, the sub-G 1 peak increased in a time-dependent manner [from 4.7% to 10.2 (24 h) and 52.0% (48 h) (Fig. 3) ]. These results suggested that the cells had undergone apoptotic cell death after treatment with compound 1.
Caspases are known to mediate the apoptotic pathway. 24, 25) In order to clarify the mechanism by which compound 1 induces apoptotic cell death in HL-60 cells, activation of caspases-3, -8, and -9 was evaluated by Western blot analysis. Cleaved caspases-3, -8, and -9 were expressed after treatment of HL-60 with compound 1 (50 nm) for 12, 24, and 36 h, respectively (Fig. 4A) . These results indicated that compound 1 induced apoptotic cell death via both the mitochondrial and death receptor mediated pathways by activation of caspases-3, -8, and -9 in HL-60 cells. Next, we assessed the effect of compound 1 on Bid, truncated-Bid (tBid), Bax, and Bcl-2. The pro-apoptotic proteins Bax and Bid, and the anti-apoptotic mitochondrial protein Bcl-2 are important regulators of cytochrome c release from mitochondria. 26, 27) Expression of these proteins was investigated by Western blot analysis. Treatment of HL-60 cells by compound 1 (50 nm) decreased the level of Bid and increased the level of tBid in a time-dependent manner (Fig. 4B) . It was reported that caspase-8 could truncate Bid, and tBid could activate the mitochondrial pathway. 28) In addition, treatment of HL-60 cells by 1 decreased the level of Bcl-2 while increased the level of Bax (Fig. 4B) . The Bax/ Bcl-2 ratio is one of the indices of the intrinsic mechanism of apoptosis in mitochondria. 29) Since compound 1 increased this ratio in HL-60 cells, it seems that compound 1-induced apoptosis involved Bax/Bcl-2 signal transduction. Compound 1 is, therefore, suggested to induce apoptosis in HL-60 cells by involving both the mitochondrial-and death receptor-signal transduction pathways. It was reported that Fas receptor, a known death receptor which induces apoptosis, can activate the necrotic pathway.
30) The necrotic cell death of AZ521 by compound 1 was, therefore, supposed to be induced by the participation of Fas receptor signaling although it is not certain whether caspase-8 is activated by Fas receptor.
Plant secondary metabolites and their semi-synthetic derivatives continue to play an important role in anticancer drug therapy. 31) From the results of cytotoxicity test, compound 1, which induced apoptotic cell death via both the mitochondrialand death receptor-mediated pathways in leukemia cells, may be a promising lead compound for developing an effective drug for leukemia.
